Product NDC: | 0025-1710 |
Proprietary Name: | Inspra |
Non Proprietary Name: | EPLERENONE |
Active Ingredient(s): | 25 mg/1 & nbsp; EPLERENONE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0025-1710 |
Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021437 |
Marketing Category: | NDA |
Start Marketing Date: | 20020927 |
Package NDC: | 0025-1710-02 |
Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0025-1710-02) |
NDC Code | 0025-1710-02 |
Proprietary Name | Inspra |
Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0025-1710-02) |
Product NDC | 0025-1710 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | EPLERENONE |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20020927 |
Marketing Category Name | NDA |
Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
Substance Name | EPLERENONE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |